Literature DB >> 32152204

Amylin/Calcitonin Receptor-Mediated Signaling in POMC Neurons Influences Energy Balance and Locomotor Activity in Chow-Fed Male Mice.

Bernd Coester1, Christina Koester-Hegmann1, Thomas A Lutz1, Christelle Le Foll2.   

Abstract

Amylin, a pancreatic hormone and neuropeptide, acts principally in the hindbrain to decrease food intake and has recently been shown to act as a neurotrophic factor to control the development of area postrema → nucleus of the solitary tract and arcuate hypothalamic nucleus → paraventricular nucleus axonal fiber outgrowth. Amylin is also able to activate ERK signaling specifically in POMC neurons independently of leptin. For investigation of the physiological role of amylin signaling in POMC neurons, the core component of the amylin receptor, calcitonin receptor (CTR), was depleted from POMC neurons using an inducible mouse model. The loss of CTR in POMC neurons leads to increased body weight gain, increased adiposity, and glucose intolerance in male knockout mice, characterized by decreased energy expenditure (EE) and decreased expression of uncoupling protein 1 (UCP1) in brown adipose tissue. Furthermore, a decreased spontaneous locomotor activity and absent thermogenic reaction to the application of the amylin receptor agonist were observed in male and female mice. Together, these results show a significant physiological impact of amylin/calcitonin signaling in CTR-POMC neurons on energy metabolism and demonstrate the need for sex-specific approaches in obesity research and potentially treatment.
© 2020 by the American Diabetes Association.

Entities:  

Year:  2020        PMID: 32152204     DOI: 10.2337/db19-0849

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  6 in total

Review 1.  Mediators of Amylin Action in Metabolic Control.

Authors:  Christina N Boyle; Yi Zheng; Thomas A Lutz
Journal:  J Clin Med       Date:  2022-04-15       Impact factor: 4.964

2.  Calcitonin receptor antibody validation and expression in the rodent brain.

Authors:  Erica R Hendrikse; Tayla A Rees; Zoe Tasma; Christelle Le Foll; Thomas A Lutz; Andrew Siow; Peter J Wookey; Christopher S Walker; Debbie L Hay
Journal:  Cephalalgia       Date:  2022-04-11       Impact factor: 6.075

3.  The long-acting amylin/calcitonin receptor agonist ZP5461 suppresses food intake and body weight in male rats.

Authors:  Lauren M Stein; Lauren E McGrath; Rinzin Lhamo; Kieran Koch-Laskowski; Samantha M Fortin; Jolanta Skarbaliene; Tamara Baader-Pagler; Rasmus Just; Matthew R Hayes; Elizabeth G Mietlicki-Baase
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-07-14       Impact factor: 3.210

Review 4.  Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat.

Authors:  David S Mathiesen; Asger Lund; Tina Vilsbøll; Filip K Knop; Jonatan I Bagger
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-08       Impact factor: 5.555

Review 5.  Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease.

Authors:  Laurie L Baggio; Daniel J Drucker
Journal:  Mol Metab       Date:  2020-09-25       Impact factor: 7.422

6.  Mouse Microglial Calcitonin Receptor Knockout Impairs Hypothalamic Amylin Neuronal pSTAT3 Signaling but Lacks Major Metabolic Consequences.

Authors:  Bernd Coester; Thomas A Lutz; Christelle Le Foll
Journal:  Metabolites       Date:  2022-01-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.